3i appoints US healthcare business expert as lead partner
This article was originally published in Clinica
Executive Summary
The North American healthcare division of private equity firm 3i (London, UK) has appointed John Moore as its lead partner. His chief remit will be to support the expansion of 3i’s healthcare investment strategy across the US. Mr Moore’s experience of healthcare business in this region is described by 3i as “extensive”. He joins from Morgan Stanley, where he was most recently head of global healthcare banking. He is the president of the Irvington Institute for Immunological Research.